![In vivo imaging of synaptic loss in spinocerebellar ataxia type 3 with [18F]SDM-8 positron emission tomography | Journal of Nuclear Medicine In vivo imaging of synaptic loss in spinocerebellar ataxia type 3 with [18F]SDM-8 positron emission tomography | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/supplement_1/262/F1.large.jpg)
In vivo imaging of synaptic loss in spinocerebellar ataxia type 3 with [18F]SDM-8 positron emission tomography | Journal of Nuclear Medicine
![Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-018-0261-9/MediaObjects/13024_2018_261_Fig4_HTML.png)
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text
![Spinocerebellar ataxias: prospects and challenges for therapy development | Nature Reviews Neurology Spinocerebellar ataxias: prospects and challenges for therapy development | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-018-0051-6/MediaObjects/41582_2018_51_Fig1_HTML.png)
Spinocerebellar ataxias: prospects and challenges for therapy development | Nature Reviews Neurology
![Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias | SpringerLink Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13311-018-00696-y/MediaObjects/13311_2018_696_Fig1_HTML.png)
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias | SpringerLink
![Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study - The Lancet Neurology Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study - The Lancet Neurology](https://www.thelancet.com/cms/asset/fb6d7c90-8847-4c2d-ac49-86187cdfa14c/gr1.jpg)
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study - The Lancet Neurology
![Relationship of repeat length to disease features in spinocerebellar... | Download Scientific Diagram Relationship of repeat length to disease features in spinocerebellar... | Download Scientific Diagram](https://www.researchgate.net/publication/322325802/figure/fig1/AS:898340111802370@1591192381847/Relationship-of-repeat-length-to-disease-features-in-spinocerebellar-ataxia-type-3-SCA3.jpg)
Relationship of repeat length to disease features in spinocerebellar... | Download Scientific Diagram
![Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-018-0261-9/MediaObjects/13024_2018_261_Fig5_HTML.png)
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text
![Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-018-0261-9/MediaObjects/13024_2018_261_Fig3_HTML.png)
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text
![Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-018-0261-9/MediaObjects/13024_2018_261_Fig2_HTML.png)